Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources

Paraganglioma Clinical Trials Near Me

As of November 13, 2026, 31 Paraganglioma clinical trials are recruiting now and 9 are not yet recruiting. In the US, 17 of them have at least 1 open site, across 22 states. Enter your ZIP code below to see which are closest to you.

Also on Trial Friend:Paraganglioma pageMatch Me

Trial Friend never receives or stores your ZIP code. Your browser looks up its location with a free map service.
Distance
Status
Ages
Phase
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+27 more

All 31 Paraganglioma trials and their US sites

Enter your ZIP code above to sort them by how far their nearest open site is from you.

  1. Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
    Most sites in Florida, Michigan and Ohio
    RecruitingPhase 1/2Ages 18-90Perspective Therapeutics
    20US sites
    15 states
  2. Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
    Most sites in Illinois, Maryland and California
    RecruitingPhase 2Ages 12+Merck Sharp & Dohme
    10US sites
    8 states
  3. Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
    Most sites in California, Colorado and Michigan
    RecruitingPhase 2Ages 18+Jazz Pharmaceuticals
    9US sites
    8 states
  4. Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
    Only in California
    RecruitingPhase 1Ages 18-75Anusha Kalbasi
    3US sites
  5. [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
    Only in Maryland
    RecruitingPhase 1Ages 18-120National Cancer Institute (NCI)
    1US site
  6. 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
    Only in Maryland
    RecruitingPhase 2Ages 18-120National Cancer Institute (NCI)
    1US site
  7. 68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
    Only in New York
    RecruitingPhase 4Ages 18-100Weill Medical College of Cornell University
    1US site
  8. A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
    Only in Maryland
    RecruitingPhase 1Ages 18-120National Cancer Institute (NCI)
    1US site
  9. Familial Investigations of Childhood Cancer Predisposition
    Only in Tennessee
    RecruitingSt. Jude Children's Research Hospital
    1US site
  10. Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
    Only in Texas
    RecruitingThe University of Texas Health Science Center at San Antonio
    1US site
  11. In Vivo PARP-1 Expression With 18F-FluorThanatrace PET/CT in Patients With Pheochromocytoma and Paraganglioma
    Only in Pennsylvania
    RecruitingEarly Phase 1Ages 18+Heather Wachtel
    1US site
  12. Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
    Only in Maryland
    RecruitingPhase 2Ages 18-100National Cancer Institute (NCI)
    1US site
  13. Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy
    Only in Maryland
    RecruitingPhase 1/2Ages 18-120National Cancer Institute (NCI)
    1US site
  14. Using the EHR to Advance Genomic Medicine Across a Diverse Health System
    Only in Pennsylvania
    RecruitingAges 18+University of Pennsylvania
    1US site
  15. "Receptor Radionuclide Therapy With 177Lu-DOTATOC
    RecruitingPhase 2Ages 18+Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
    No US site yet
  16. 18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
    RecruitingEarly Phase 1Ages 1-80Peking Union Medical College Hospital
    No US site yet
  17. Adrenal Diseases in the Population of Modena: A Clinical-Epidemiological Database of Patients Referred to the Adrenal Disorders Outpatient Clinic of the Clinical Unit of Endocrinology at the Modena University Hospital (AOU Modena)
    RecruitingAges 18+Azienda Ospedaliero-Universitaria di Modena
    No US site yet
  18. Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma
    RecruitingAges 18-80Peking Union Medical College Hospital
    No US site yet
  19. An Experimental Study of Belzutifan Impact on Catecholamine Metabolism
    RecruitingPhase 2Cambridge University Hospitals NHS Foundation Trust
    No US site yet
  20. An International Study on Pediatric Patients With Rare Tumors.
    RecruitingAges 0-18Azienda Ospedaliera di Padova
    No US site yet
Get an email when Paraganglioma trials change

New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.

You'll get, for Paraganglioma:
  • Trial Alerts, when a new trial opens or a trial changes
  • Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Turn either off anytime from the link in every email.
We never share your email. Unsubscribe anytime. Privacy policy · Check any health site

Who runs the Paraganglioma trials in the US, and what stage they are in

None of the 17 Paraganglioma trials with a US site is in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 13 of them. One is a Phase 4 study of an already approved treatment. The remaining 3 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 3 of them, and universities, hospitals, foundations and government groups run 14. The sponsors with the most are National Cancer Institute (NCI) (5) and University of Pennsylvania (2). The most recently listed one first appeared on ClinicalTrials.gov on August 3, 2026.

Paraganglioma trials in the US, state by state

Of the 17 Paraganglioma trials with a US site, 3 accept children under 18. Their open sites are in 8 states, most often Tennessee, Texas and California. A trial counts once in each state where it has an open site, and some trials accept both children and adults.

StateTrialsChildrenAdultsCities with the most
Maryland717Bethesda (6), Baltimore (2)
Pennsylvania404Philadelphia (4)
California313Los Angeles (3), Duarte (1), Palo Alto (1), plus 1 more
Michigan313Ann Arbor (2), Detroit (1), Grand Rapids (1), plus 1 more
Tennessee323Nashville (2), Memphis (1)
Texas323Houston (2), San Antonio (1)
Illinois212Chicago (2), Warrenville (1)
Iowa212Iowa City (2)
Massachusetts212Boston (2)
Minnesota202Rochester (2)
Show the other 12 states
Missouri202St Louis (2)
New York202New York (2)
Colorado101Aurora (1)
Florida101Jacksonville (1), Miami (1), Orlando (1)
Kentucky101Lexington (1)
Nebraska101Omaha (1)
North Carolina101Chapel Hill (1)
Ohio101Cleveland (1), Columbus (1)
Utah101Salt Lake City (1)
Virginia101Fairfax (1)
Washington101Seattle (1)
Wisconsin101Milwaukee (1)

US hospitals running the most Paraganglioma trials

Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Paraganglioma.

  1. National Institutes of Health Clinical CenterBethesda, Maryland5 trials
  2. Washington UniversitySt Louis, Missouri2 trials
  3. Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, Pennsylvania1 trial
  4. Advent Health Radiation Oncology at Central FloridaOrlando, Florida1 trial
  5. BAMF HealthGrand Rapids, Michigan1 trial
  6. Barbara Ann Karmanos Cancer InstituteDetroit, Michigan1 trial
  7. Biogenix MolecularMiami, Florida1 trial
  8. Brigham and Women's Hospital (BWH)Boston, Massachusetts1 trial
  9. Cedars-Sinai Medical Center ( Site 0110)Los Angeles, California1 trial
  10. City of HopeDuarte, California1 trial

Help getting to a Paraganglioma trial far from home

Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.

These nonprofits also help patients reach care, and each one sets its own rules.

Mercy Medical Angels
Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
Air Charity Network
Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
Corporate Angel Network
Puts cancer patients in empty seats on business jets for treatment, second opinions and clinical trials. Open to anyone with cancer who can walk and travel without medical help, and it does not check income.
American Cancer Society Hope Lodge
Offers a free place to stay at 31 Hope Lodge locations for people getting cancer treatment far from home. People facing cancer and their caregivers, when treatment is far from home.
Ronald McDonald House
Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
Healthcare Hospitality Network
Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.

Program details were checked on each program's website on October 24, 2026.

Questions about finding a Paraganglioma trial near you

Are there Paraganglioma clinical trials near me?

As of November 13, 2026, 31 Paraganglioma clinical trials are recruiting now and 9 are not yet recruiting. In the US, 17 of them have at least 1 open site, across 22 states. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.

Which states have Paraganglioma clinical trial sites?

Recruiting Paraganglioma trials list open sites in 22 states. Maryland, Pennsylvania and California have the most, and the table on this page lists every state.

Are there Paraganglioma trials for children near me?

Of the 17 Paraganglioma trials with a US site, 3 accept children under 18. Their open sites are in 8 states, most often Tennessee, Texas and California. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.

Who pays for travel to a Paraganglioma clinical trial?

Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights, and Corporate Angel Network flies cancer patients for free.

What if there is no Paraganglioma trial near me?

Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Paraganglioma trial opens a new site or changes status.

How is the distance to a trial site measured?

Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.

FDA-approved for Paraganglioma: Welireg (belzutifan).

Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.